Neutrophil to lymphocyte ratio and cardiovascular diseases: a review
By Tariq M. Bhat, S. Teli, Jharendra P Rijal, H. Bhat, Muhammad Raza, Georges Khoueiry, Mustafain Meghani, Muhammad Akhtar, T. Costantino. Expert Review of Cardiovascular Therapy, 2013
729 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Epidemiology, Oncology
View Paper: https://www.semanticscholar.org/paper/20f72a62bd0fb6168c535b32e7a60016689f3ff0
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- A. Tomasi
- G. Ponti
- C. Ruini
- T. Ozben
- M. Maccaferri
Citations in the corpus
- Biomarkers associated with COVID-19 disease progression (2020, background): “The NLR, calculated simply by the ratio of neutrophils count/lymphocytes count, is an inflammatory marker that can predict the probability of death in patients with various cardiovascular diseases [36,37].”